The need for modern medicine to extend quality life for the whole population requires new technologies and models for testing interventions. As well as performing high quality research the CMCiB develops innovative tools for carrying it out. Here are some of our products.
Research
CMCiB renews its certificate of compliance with Good Laboratory Practices (GLP) for the preclinical validation of medical devices
CMCiB-IGTP has renewed its certificate of compliance with Good Laboratory Practices (GLP) in accordance with Directive 2004/9/EC.
StoryThe international consortium INNOVA4TB wraps up five years of cutting-edge tuberculosis research
On 21 March, the final meeting of INNOVA4TB, a consortium led by IGTP with researchers from around the world, took place. Participants presented the results of the different work packages and evaluated the work done since 2019. IGTP will continue to be involved in other networks such as ADVANCE-TB and SMA-TB.
StoryThe podcast 'Un bri de ciència' addresses neuromuscular diseases on World Rare Disease Day
Coinciding with World Rare Disease Day, IGTP launches a new episode of its podcast 'Un bri de ciència'. Researcher Gisela Nogales discusses her projects on neuromuscular diseases and emphasises her commitment to supporting patients and providing solutions.
StoryThirteen researchers from IGTP bring science closer to students in the 6th edition of #100tífiques
On 7 February, "#100tífiques" returned for its sixth edition, a macro-event that has become a benchmark for advocacy within the Catalan female research community and schools. Expanding on last year's participant numbers, thirteen scientists from IGTP took part in this event.
StoryCan Ruti addresses current advances and challenges in female leadership in science
For the sixth consecutive year and in honour of the International Day of Women and Girls in Science, the Can Ruti Working Group Women for Equity in Science (formerly known as Women in Science) organised a symposium to reflect on the status of women in science. The event was held yesterday, 8 February, at the Germans Trias i Pujol Research Institute (IGTP) and was attended by over a hundred people in person and online. It focused on "Women and Leadership in Science".
StoryThe European Union launches the THRIVE project to improve the prognosis of children and adults with liver cancer
The European Union's project THRIVE held its kick-off meeting on 12 January 2024 in Barcelona. The project is coordinated by Josep M. Llovet (IDIBAPS). IGTP collaborates as a partner through c-LOG, led by Carolina Armengol.
StoryEuropean scientists unite in the quest for breakthroughs in immunotherapy treatments
The network IMMUNO-model has brought together researchers and innovators from all over the world to foster research in immuno-oncology through the advancement in the development and implementation of pre-clinical models. This initiative is funded by the European Cooperation in Science and Technology (COST) programme.
StoryCEEISCAT shares the results of the TÉSTATE project on HIV and hepatitis C
Two studies by CEEISCAT-IGTP have evaluated an online HIV and HCV self-testing strategy, demonstrating that it is effective and safe.
StoryA year in review: 2023 highlights at IGTP
In 2023, the IGTP has continued to make significant strides in its mission. Here, we review the year's top news stories, reflecting the persistent drive and collaborative spirit that underpin this institution.
StoryThe Talents programme awards grants to research projects from around twenty health professionals affiliated with Germans Trias
Fundació Catalunya La Pedrera provides these awards, supporting and enhancing the careers of young talents with both its own resources and contributions from the ICS Gerència Territorial Metropolitana Nord.
StoryThe third IGTP Scientific Retreat proves a success
The IGTP Retreat consolidates as a nexus of the research carried out at the Can Ruti Campus. This year the event has focused on ageing and a patient-centred model of care.
Story‘Un bri de ciència’ dedicates an episode to stroke to commemorate World Stroke Day
The podcast from the Germans Trias i Pujol Research Institute (IGTP) launches a new episode titled "Stroke: a race against the clock"). Researcher and clinician Mònica Millán explains what everyone should know about this pathology, as well as the research her group is conducting to improve the lives of patients.
StoryTwo projects from IGTP funded by ”la Caixa” Foundation to transition their innovative research from the laboratory to patients
The first urine test that detects kidney fibrosis as an alternative to kidney biopsies, an initiative from the IVECAT group, and a project applying artificial intelligence to rapidly categorise stroke patients and enhance their recovery chances, from the Neurovascular Research group, are two of the fifteen projects from Catalan research centres selected within the 2023 call of the new CaixaImpulse Healthcare Innovation programme.
StoryRIGHT PLUS network formalised in Buenos Aires as a collaboration between academic centres and civil society in Ibero-America
The Ibero-American network RIGHT PLUS, of which the CEEISCAT is a founding member and, together with Coalition Plus, co-coordinator, has presented its launch at a meeting in Buenos Aires (Argentina) on 28-29 August.
StoryLatest episode of IGTP’s 'Un Bri de Ciència' takes on viral hepatitis
To mark World Hepatitis Day, the podcast 'Un Bri de Ciència' dedicates an episode to viral hepatitis, specifically focusing on Hepatitis B and C, which are considered to be the most severe types. Researcher Elisa Martró unravels what we know about these diseases and discusses her projects, both in the hospital setting and in communities, working with vulnerable populations. The podcast enhances the mission of awareness and dissemination of IGTP.
StoryIGTP wraps up successful round of La Marató visits to its laboratories
The four visits under the "Visita la recerca" (Visit the research) cycle of the Fundació La Marató de TV3 at the Germans Trias i Pujol Research Institute (IGTP) have drawn to a successful close. More than 50 collaborators have had the opportunity to gain insight into various research projects funded through this charitable initiative.
StoryThe Catalan Minister Nadal highlights "the uniqueness" of facilities like the Comparative Medicine and Bioimage Centre in the research system that promotes "biomedical innovation"
The Catalan Minister of Research and Universities meets with the management team of the CMCiB, which is one of the strategic projects driven by the Germans Trias i Pujol Research Institute (IGTP).
StoryIGTP, IQS (URL) and BST are working together to develop bypass surgery using donor veins
One of the most commonly practised cardiovascular health interventions, the coronary bypass, could undergo a revolutionary innovation with the joint research carried out by the Blood and Tissue Bank (BST), the Germans Trias i Pujol Research Institute (IGTP) and the Vascular Engineering and Applied Biomedicine Group (GEAB) of the IQS (URL). The three centres are working to develop a vascular graft from donor veins that can be used for bypass surgery to restore blood flow.
StoryTwo IGTP groups lead a European analysis to understand key factors for digitalisation in practice environments
The research groups in Nursing Care (NURECARE) and Innovation, Health Economics and Digital Transformation (INEDIT) from the IGTP are leading the publication of the first report on the key factors for introducing digital technologies in professional nursing practice environments. Through this effort, professionals from the Germans Trias Hospital are participating for the first time in the design of a comprehensive analysis of the required changes, while also offering recommendations to ensure the success of any initiative aimed at incorporating these technologies into hospitals.
StoryIGTP introduces super-resolution microscope at CMCiB
A state-of-the-art super-resolution fluorescence confocal microscope, called Abberior Infinity, was installed in the high-level biosafety (NCB3) facility of the Centre for Comparative Medicine and Bioimage (CMCiB). The equipment of this class, unique in the region, is a powerful tool for anyone aiming to perform advanced microscopy studies on fully infectious Level 3 pathogens (HIV, SARS-CoV-2, Monkey Pox, TB etc.) The microscope is available for use by all internal and external users via IGTP Microscopy Platform.
StoryHyposfix, a new medical device to improve paediatric urological surgeries, has been developed by researchers at Germans Trias Hospital, with support from IGTP
The expertise and innovation spirit of researchers at Germans Trias Hospital's Paediatric Surgery Service has resulted in a new medical device for the treatment of hypospadias: Hyposfix, a urological separator-fixator. This device, which will be launched to market soon, is the result of an idea and a project led at Germans Trias i Pujol Research Institute (IGTP).
StoryCMCiB participates in the preclinical studies of Rob Surgical's surgical robot, the first one designed and manufactured in Catalonia
The centre reaches a milestone in its track-record by adding the first Good Laboratory Practice study in its portfolio where the tested product at the centre will reach clinical trials in humans in accordance with international Good Clinical Practice.
StoryThe podcast 'Un bri de ciència' explores type 1 diabetes in its second episode
The new episode of the podcast 'Un bri de ciència' is presented under the title "La diabetis tipus 1: quan la defensa t'ataca" (Type 1 diabetes: when your defences attack you). Researcher Marta Vives Pi explains the problems of autoimmune diseases, with an emphasis on type 1 diabetes.
StoryIGTP premieres the podcast ‘Un bri de ciència’
In the first episode, "La tuberculosi: la pandèmia dels pobres" (Tuberculosis: the pandemic of the poor), researcher José Domínguez explains the basics of the disease and the current situation of research. This podcast is a way for the centre to reach a wide audience, thanks to a short and dynamic storytelling format.
StoryThe Clinical and Environmental Infectious Diseases Research Group signs a collaboration for the development of a new biocide for the treatment of drinking water
The Clinical and Environmental Infectious Diseases Research Group (CEID) has discovered a molecule of natural origin with a high bactericidal, amoebicidal and biofilm reduction capacity. The collaboration signed by the group's researchers with a private company will finance the improvement of the molecule's characteristics to be applied in large water installations, preventing water for human consumption from acting as a vehicle for the transmission of bacterial diseases.
StoryMesenchymal stem cells reveal mechanisms of action in regulatory B cells independent of interleukin-10 useful for their identification and monitoring
Researchers from the REMAR-IVECAT ("Kidney Related Diseases Research" and "Innovation in VEsicles and Cells for Application in Therapy") group, from the Germans Trias i Pujol Research Institute (IGTP), identify molecular pathways in regulatory B cells that are essential for their therapeutic applications. In the article that has been recently published in Frontiers in Immunology, the use of mesenchymal stem cells has allowed distinguishing the molecules that are essential to monitoring regulatory B cells in kidney transplants.
StoryBioimplants with extra-cellular vesicles from stem cells can improve cardiac function after an acute myocardial heart attack
Researchers from the ICREC Group (Cardiac Insufficiency and Regeneration) in cardiovascular diseases at the Germans Trias i Pujol Research Institute (IGTP) continue to work on therapeutic technologies to repair cardiac tissue after a heart attack. In an article published in Theranostics, they present a study of extracellular vesicles from mesenchymal stem cells combined with tissue engineering as a therapy to repair the heart after a heart attack. They have carried out the study on a porcine heart attack model at the Centre for Comparative Medicine and Bioimage (CMCiB) at the IGTP.
StoryTime is Brain, Spin-off company from the IGTP, closes its financing round in little more than an hour
The seed-funding round for the IGTP Spin-off Time is Brain has reached its financing objective in record time almost as soon as it opened. The company opened the round on the platform Capital Cell and has not only reached the goal of 640,000, but has passed it and received 800,000, the figure the spin-off had set as a maximum.
StoryMireia Ramos Rodríguez is awarded the prize for the Best Research Paper by a Predoctoral Student by the Catalan Institute of Health
Mireia Ramos Rodríguez is a bioinformatics post-doctoral researcher; she focusses on defining the changes in cis-regulatory elements that can lead to the development of disease and programming to provide tools for other researchers to carry out their analyses. She has been awarded the Prize for Best Research Paper in Health by a Predoctoral Researcher for her article published in Nature Genetics.
Story
Virtual lungs to understand the dynamics of tuberculosis lesions within the lungs
The study focusses on understanding the mechanisms that keep the infection latent without the infected person developing the disease. 90% of people infected never develop the active disease, understanding this mechanism so that we can identify them is key to eradicating tuberculosis. The research has been carried out in virtual lungs, developed by computational modelling techniques. These are the first results to be published by the 3Rs Programme at the Centre for Comparative Medicine and Bioimage (CMCiB) which aims to minimize the use of animals in pre-clinical research.
Story